SCHEMBL24546320

SCHEMBL24546320

Clc1ccc2oc3ccc4oc(-c5ccccc5)nc4c3c2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.60
CASP3 P42574 2/20 0.60
SENP7 Q9BQF6 2/20 0.60
SENP6 Q9GZR1 2/20 0.60
AHR P35869 4/20 0.49
ADORA3 P0DMS8 2/20 0.47
TNKS O95271 1/20 0.47
RCE1 Q9Y256 1/20 0.45
RAB9A P51151 5/20 0.44
KDM4E B2RXH2 4/20 0.44
NPC1 O15118 4/20 0.44
NPSR1 Q6W5P4 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
HTT P42858 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
HPGD P15428 3/20 0.43
NFKB1 P19838 2/20 0.43
NFKB2 Q00653 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24545232 0.90 SMN1; SMN2 (0.58) SMN1; SMN2CASP3SENP7SENP6AHR
SCHEMBL25729949 0.87 SMN1; SMN2 (0.58) SMN1; SMN2CASP3SENP7SENP6ADORA3
SCHEMBL26450514 0.87 MKNK2 (0.47) SMN1; SMN2CASP3SENP7SENP6AHR
SCHEMBL24546306 0.87 MAPT (0.46) SMN1; SMN2CASP3SENP7SENP6AHR
SCHEMBL25551888 0.85 SMN1; SMN2 (0.63) SMN1; SMN2CASP3SENP7SENP6ADORA3
SCHEMBL27383292 0.83 SMN1; SMN2 (0.57) SMN1; SMN2CASP3SENP7SENP6ADORA3
SCHEMBL25898358 0.83 SMN1; SMN2 (0.60) SMN1; SMN2CASP3SENP7SENP6ADORA3
SCHEMBL24547228 0.81 AHR (0.44) SMN1; SMN2CASP3SENP7SENP6AHR
SCHEMBL25551820 0.81 SMN1; SMN2 (0.61) SMN1; SMN2CASP3SENP7SENP6ADORA3
SCHEMBL24546994 0.81 SMN1; SMN2 (0.61) SMN1; SMN2CASP3SENP7SENP6AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230363266-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-11-09 US disclosed
US-20230363266-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2023-11-09 US disclosed
EP-4254527-A1 ORGANIC LIGHT EMITTING DEVICE Lg Chem, Ltd. (KR) 2023-10-04 EP disclosed
WO-2022131757-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2022-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230363266-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME DRD1, OPRD1, NR1D1 SMN1; SMN2 1411/4885CASP3 3141/4885SENP7 3128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.